Drug and Alcohol Dependence
Volume 95, Issue 3 , Pages 199-208 , 1 June 2008

Smoking tobacco along with marijuana increases symptoms of cannabis dependence

  • Geoffrey L. Ream

      Affiliations

    • 341 School of Social Work Building, Adelphi University, 1 South Avenue, P.O. Box 701, Garden City, NY 11530, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 516 877 4432; fax: +1 516 877 4392.
    • ,
  • Ellen Benoit

      Affiliations

    • Institute for Special Populations Research, National Development and Research Institutes, 71West 23rd Street, 14th Floor, New York, NY 10010, USA
    • ,
  • Bruce D. Johnson

      Affiliations

    • Institute for Special Populations Research, National Development and Research Institutes, 71West 23rd Street, 14th Floor, New York, NY 10010, USA
    • ,
  • Eloise Dunlap

      Affiliations

    • Institute for Special Populations Research, National Development and Research Institutes, 71West 23rd Street, 14th Floor, New York, NY 10010, USA

Received 22 August 2007 ,Revised 31 December 2007 ,Accepted 1 January 2008.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed.. Washington, DC: American Psychiatric Association; 2000;
  2. Amos A, Wiltshire S, Bostock Y, Haw S, McNeill A. ’You can’t go without a fag … you need it for your hash’—a qualitative exploration of smoking, cannabis and young people. Addiction. 2004;99:77–81
  3. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R. Delta 9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur. J. Neurosci. 2004;20:2737–2748
  4. Balerio GN, Aso E, Maldonado R. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology. 2006;184:504–513
  5. Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn. Mem. 2004;11:625–632
  6. Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology. 2002;43:857–867
  7. Castane A, Berrendero F, Maldonado R. The role of the cannabinoid system in nicotine addiction. Pharmacol. Biochem. Behav. 2005;81:381–386
  8. Centers for Disease Control and Prevention, 2007. YRBSS – Youth risk behavior surveillance system – DASH/HealthyYouth. http://www.cdc.gov/HealthyYouth/yrbs/index.htm (accessed on November 15, 2007).
  9. Chhatwal JP, Ressler KJ. Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectr. 2007;12:211–220
  10. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005;30:516–524
  11. Cohen C, Kodas E, Griebel G. CB1 receptor antagonists for the treatment of nicotine addiction. Pharmacol. Biochem. Behav. 2005;81:387–395
  12. Cohen C, Perrault G, Griebel G, Soubrie P. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, Rimonabant (SR141716). Neuropsychopharmacology. 2005;30:145–155
  13. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291:2114–2121
  14. Denson TF, Earleywine M. Decreased depression in marijuana users. Addict. Behav. 2006;31:738–742
  15. Denson, T.F., Earleywine, M., 2006. Pothead or pot smoker? A taxometric investigation of cannabis dependence. Substance Abuse Treatment, Prevention, and Policy, 1, http://www.substanceabusepolicy.com/content/1/1/22 (accessed on September 18, 2007).
  16. Dunlap E, Johnson BD, Sifaneck SJ, Benoit E. Sessions, cyphers, and parties: settings for informal social controls of blunt smoking. J. Ethn. Subst. Abuse. 2005;4:43–80
  17. Dunlap E, Benoit E, Sifaneck SJ, Johnson BD. Social constructions of dependency by blunts smokers: qualitative reports. Int. J. Drug Policy. 2006;17:171–182
  18. European Monitoring Centre for Drugs and Drug Addiction, 2004. EMCDDA INSIGHTS—an overview of cannabis potency in Europe. http://www.emcdda.europa.eu/index.cfm?fuseaction=public.AttachmentDownload&nNodeID=2950&sLanguageISO=EN (accessed on September 18, 2007).
  19. Farquhar-Smith WP. Pain and cannabinoids: science and evidence. Pain Rev. 2002;9:41–67
  20. Ford DE, Vu H-T, Anthony JC. Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug Alcohol Depend. 2002;67:243–248
  21. Forget B, Hamon M, Thiebot M-H. Cannabinoid CB-sub-1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology. 2005;181:722–734
  22. In:  Golub A editors. The Cultural/Subcultural Contexts of Marijuana Use at the Turn of the Twenty-first Century. Binghamton, NY: Haworth; 2006;
  23. Humfleet GL, Haas AL. Is marijuana use becoming a ’gateway’ to nicotine dependence?. Addiction. 2004;99:5–6
  24. Johnson BD, Golub A. Dependence on and treatment for street drugs among Manhattan arrestees. In:  Cole SM editors. New Research on Street Drugs. Hauppauge, NY: Nova Science Publishers; 2006;p. 13–29
  25. Johnson BD, Bardhi F, Sifaneck SJ, Dunlap E. Marijuana argot as subculture threads: Social constructions by users in New York City. Br. J. Criminol. 2006;46:46–77
  26. Johnston, L. D., Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., 2006. Monitoring the future: a continuing study of American youth (12th-grade survey), 2006. http://www.icpsr.umich.edu/cocoon/SAMHDA/STUDY/20022.xml (accessed on November 15, 2007).
  27. Le Foll B, Wiggins M, Goldberg SR. Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats. Behav. Pharmacol. 2006;17:195–199
  28. Marco EM, Llorente R, Moreno E, Biscaia JM, Guaza C, Viveros MP. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats. Behav. Brain Res. 2006;172:46–53
  29. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio M-G, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418:530–534
  30. Patton GC, Coffey C, Carlin JB, Sawyer SM, Wakefield M. Teen smokers reach their mid twenties. J. Adolesc. Health. 2006;39:214–220
  31. Penetar DM, Kouri EM, Gross MM, McCarthy EM, Rhee CK, Peters EN, et al. Transdermal nicotine alters some of marihuana's effects in male and female volunteers. Drug Alcohol Depend. 2005;79:211–223
  32. Ream GL, Johnson BD, Sifaneck SJ, Dunlap E. Distinguishing blunts users from joints users: a comparison of marijuana use subcultures. In:  Cole SM editors. New Research on Street Drugs. Hauppauge, NY: Nova Science Publishers; 2006;p. 245–273
  33. Research Triangle Institute, 2007. 2007 National survey on drug use and health: CAI specifications for programming, English version. http://www.oas.samhsa.gov/nsduh/2k7MRB/2k7Q.pdf (accessed on September 18, 2007).
  34. Roffman RA, Stephens RS. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge, UK: Cambridge University Press; 2006;
  35. Substance Abuse and Mental Health Services Administration: Office of Applied Studies, 1999. National household survey on drug abuse: 1999 nonresponse analysis report. http://www.oas.samhsa.gov/nhsda/nonresponse99/tocW.pdf (accessed on September 18, 2007).
  36. Sifaneck SJ, Johnson BD, Dunlap E. Cigars-for-blunts: marketing of flavored tobacco products to youth and minorities. J. Ethn. Subst. Abuse. 2005;4:23–42
  37. Sifaneck SJ, Ream GL, Johnson BD, Dunlap E. Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram. Drug Alcohol Depend. 2007;90S:S40–S51
  38. Smith NT. A review of the published literature into cannabis withdrawal symptoms in human users. Addiction. 2002;97:621–632
  39. Soellner R. Dependence on cannabis—an ever lasting issue. Subst. Use Misuse. 2005;40:857–867
  40. Timberlake DS, Haberstick BC, Hopfer CJ, Bricker J, Sakai JT, Lessem JM, et al. Progression from marijuana use to daily smoking and nicotine dependence in a national sample of US. adolescents. Drug Alcohol Depend. 2007;88:272–281
  41. Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br. J. Pharmacol. 2002;135:564–578
  42. Viveros M-P, Marco EM, File SE. Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci. Biobehav. Rev. 2006;30:1161–1181
  43. World Health Organization . International Statistical Classification of Diseases and Related Health Problems, 10th Revision. 2nd ed.. Geneva: World Health Organization; 2004;

PII: S0376-8716(08)00048-3

doi: 10.1016/j.drugalcdep.2008.01.011

Drug and Alcohol Dependence
Volume 95, Issue 3 , Pages 199-208 , 1 June 2008

Article Tools

* Image Usage & Resolution